Developmental outcome of very low birth weight infants in a developing country

Daynia E Ballot1, Joanne Potterton, Tobias Chirwa

  • 1Department of Paediatrics and Child Health, University of the Witwatersrand, PO Wits 2050, South Africa. daynia.ballot@wits.ac.za

BMC Pediatrics
|February 3, 2012
PubMed

Insights

Neurodevelopmental follow-up of very low birth weight (VLBW) infants in South Africa shows generally normal outcomes, but with a notable proportion at risk. Long-term monitoring is crucial for these vulnerable infants.

Area of Science:

  • Neonatalogy
  • Developmental Pediatrics
  • Public Health

Background:

  • Neonatal care advances increase survival of extremely premature infants, who are at risk of handicap.
  • Neurodevelopmental follow-up is essential for evaluating neonatal care, especially in resource-limited settings.
  • Data from developing countries is crucial for understanding VLBW infant outcomes.

Purpose of the Study:

  • To provide neurodevelopmental follow-up data for very low birth weight (VLBW) infants in Johannesburg, South Africa.
  • To identify factors associated with poor neurodevelopmental outcomes in this population.
  • To inform neonatal care practices in resource-limited settings.

Main Methods:

  • Study included VLBW infants discharged from Charlotte Maxeke Johannesburg Academic Hospital (CMJAH).
  • Bayley Scales of Infant and Toddler Development (BSID) III assessed development.
  • Regression analysis identified factors associated with poor outcomes.

Main Results:

  • 106 VLBW infants (mean birth weight 1182g, mean gestational age 30.81 weeks) were assessed using BSID III.
  • Mean subscale scores were within the normal range, but approximately one-third scored "at risk" (70-85).
  • Cystic periventricular leukomalacia (PVL), resuscitation at birth, and prolonged oxygen were associated with poor outcomes; birth weight and gestational age were not predictive.

Conclusions:

  • VLBW infants in this South African cohort showed generally normal neurodevelopmental outcomes with low cerebral palsy incidence.
  • Low survival of infants <900g may influence observed outcomes.
  • A significant proportion of infants were "at risk," necessitating long-term follow-up into school age.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...